GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » EBITDA Margin %

Oncodesign Precision Medicine (XPAR:ALOPM) EBITDA Margin % : -3,050.47% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Oncodesign Precision Medicine's EBITDA for the six months ended in Dec. 2024 was €-3.26 Mil. Oncodesign Precision Medicine's Revenue for the six months ended in Dec. 2024 was €0.11 Mil. Therefore, Oncodesign Precision Medicine's EBITDA margin for the quarter that ended in Dec. 2024 was -3,050.47%.

Oncodesign Precision Medicine EBITDA Margin % Historical Data

The historical data trend for Oncodesign Precision Medicine's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine EBITDA Margin % Chart

Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
-138.39 -93.87 -18.07 -882.28 -3,509.18

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EBITDA Margin % Get a 7-Day Free Trial 30.92 -614.63 -1,492.05 -4,000.00 -3,050.47

Competitive Comparison of Oncodesign Precision Medicine's EBITDA Margin %

For the Biotechnology subindustry, Oncodesign Precision Medicine's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncodesign Precision Medicine's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's EBITDA Margin % falls into.


;
;

Oncodesign Precision Medicine EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Oncodesign Precision Medicine's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-7.264/0.207
=-3,509.18 %

Oncodesign Precision Medicine's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-3.264/0.107
=-3,050.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncodesign Precision Medicine  (XPAR:ALOPM) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Oncodesign Precision Medicine EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » EBITDA Margin %
Comparable Companies
XPAR:ALTAO XPAR:ALTME XPAR:ALINT XPAR:ALTHX XPAR:ALBPS XPAR:ALVIO XPAR:ALNEV XPAR:ALPAT XPAR:ALVAL XPAR:AELIS VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
ZR8:Germany
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Website
https://www.opm.oncodesign.com
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine Headlines

No Headlines